Join to View Full Profile
3400 Spruce StPhiladelphia, PA 19104
Phone+1 215-349-8222
Dr. Bittermann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Gastroenterology, 2014 - 2017- University of Pennsylvania Health SystemResidency, Internal Medicine, 2010 - 2013
Drexel University College of MedicineClass of 2010
Certifications & Licensure
PA State Medical License 2010 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Publications & Presentations
PubMed
- Lower Child Opportunity Index is associated with increased health care utilization following pediatric liver transplantation.Aaron D Bennett, Knashawn H Morales, Yuan-Shung V Huang, Vicky Tam, Amit Shah
Liver Transplantation. 2025-02-21 - 1 citationsReal-world evidence for factors associated with maintenance treatment practices among US adults with autoimmune hepatitis.Therese Bittermann, Lina Yagan, Ranganath G Kathawate, Ethan M Weinberg, Eliot G Peyster
Hepatology. 2025-02-01 - Hospital readmission for acute kidney injury is independently associated with de novo end-stage renal disease after liver transplantation.Therese Bittermann, Ranganath G Kathawate, Douglas E Schaubel, James D Lewis, David S Goldberg
Liver Transplantation. 2025-02-01
Press Mentions
Q&A: Challenges in Living Donor Transplant for Alcohol-Associated HepatitisAugust 30th, 2024- Liver Transplants: 'Collateral Damage' of Pandemic DrinkingJuly 29th, 2021
Grant Support
- 2/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)UNIVERSITY OF PENNSYLVANIA2023–2030
- 2/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)UNIVERSITY OF PENNSYLVANIA2023–2030
- Impact of mammalian target of rapamycin inhibitor therapy on aging-related outcomesUNIVERSITY OF PENNSYLVANIA2023–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
